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4ABSTRACT
Some previously described environmental associations for atopic eczema (AE) may be due to
reverse causation. We explored the role of reverse causation by comparing individual- and
school-level results for multiple AE risk factors.
ISAAC Phase Three surveyed children within schools (the sampling unit) on AE symptoms
and potential risk factors. We assessed the effect of these risk factors on AE symptoms using
mixed-effect logistic regression models, first with individual-level exposure data and second
with school-level exposure prevalence.
546,348 children from 53 countries were included. At age 6-7 the strongest individual-level
associations were with current paracetamol use (odds ratio=1.45, 95% confidence interval
1.37-1.54), which persisted at school-level (1.55, 1.10-2.21), antibiotics (1.41, 1.34-1.48) and
early life paracetamol use (1.28, 1.21-1.36) with the former persisting at school-level while
the latter was no longer observed (1.35, 1.00-1.82 and 0.94, 0.69-1.28 respectively). At age
13-14 the strongest associations at individual-level were with current paracetamol use (1.57,
1.51-1.63) and open-fire cooking (1.46, 1.33-1.62); both were stronger at school-level (2.57,
1.84-3.59 and 2.38, 1.52-3.73 respectively). Association with exposure to heavy traffic (1.31,
1.27-1.36) also persisted at school-level (1.40, 1.07-1.82).
Most individual- and school level effects were consistent tending to exclude reverse
causation.
5INTRODUCTION
Atopic eczema (AE) prevalence has increased substantially over the last 30 years; up to 20%
of children in affluent westernized countries have AE during their lives and prevalence in
low-and-middle income countries is increasing (Odhiambo et al., 2009). AE can have a major
impact on sufferers and their families (Balkrishnan et al., 2003, Beattie and Lewis-Jones,
2006).
While genetic factors clearly play an important role in AE aetiology, the dramatic increase in
prevalence of AE in low- and middle-income countries is not consistent with a major role of
genetic factors (since these do not change rapidly over time), and strongly suggests that
environmental factors are important (Odhiambo et al., 2009, Sandilands et al., 2006).
Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) has
contributed significantly to understanding the associations between single environmental
exposures and asthma, AE and rhinitis (Asher et al., 2010). However, environmental factors
may confound each other’s effects in allergic diseases; hence assessing the role of many key
environmental factors together is useful. Findings of cross-sectional studies, including
ISAAC, may be limited by reverse causation, where the direction of cause-and-effect is
contrary to a common presumption. This arises when a child being at risk of or having AE
has led to changes in environmental exposures. For example, parents may remove pets
following AE onset if they believe pets exacerbate AE symptoms, resulting in a paradoxical
association between increased pet exposure and decreased AE when measured at a single
time point (Brunekreef et al., 2012a, Langan et al., 2007), rather than increased pet exposure
increasing AE risk. Cross-sectional studies may also be limited by confounding by indication
where the association with the risk factor has an alternative explanation; for example, AE
may be complicated by skin infections requiring antibiotic treatment, leading to an observed
6increased association between AE and antibiotic use, rather than antibiotics being on the
causal pathway for AE. Confounding by indication has been considered as an alternative
explanation in relation to paracetamol (acetaminophen) use and asthma aetiology (but not
AE) in previous ISAAC papers, although paracetamol may be taken for symptoms of severe
skin and other infections associated with AE.(Beasley et al., 2008)
In this study, we assessed the effects of the all the key environmental variables previously
each singly associated with AE in ISAAC at an individual-level, aiming to find which
variables were the most important. The individuals in ISAAC were within schools (the
sampling unit). Therefore, at the same time, we also incorporated average school-level
exposure estimates (calculated from the individual-level data) to assess whether associations
seen for these multiple variables at individual-level could be due to bias from reverse
causation.
In standard individual-level exposure models the estimated effect (here an odds ratio [OR])
corresponding to the individual-level risk factor can be interpreted as the OR of the exposed
compared to the unexposed child, after adjustment for school-level prevalence (as a random
intercept). This means bias due to reverse causation may be a concern where this is plausible,
but the estimated effects will not be confounded by unmeasured ecological factors (other
environmental factors affecting the whole population).
In school-level exposure prevalence models, the estimated OR corresponding to the school-
level prevalence of the risk factor can be interpreted as the effect on an individual of
attending a hypothetical school where all children are exposed compared to a hypothetical
school where no children are exposed. School-level analyses can suffer from ecological bias,
but there is less concern about reverse causation as the actions of a few parents will not
significantly affect the school-level prevalence of an exposure. Therefore, comparing the
7results of these models enables exploration of whether single individual-level risk factors,
which could plausibly be due to reverse causation, persist or diminish when explored at
school-level.
The complementary approach of individual- and school-level analyses used in this paper
enables exploration of mutual confounding by environmental factors and different forms of
reverse causation, including avoidance bias and confounding by indication.
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6-7 year olds
The 6-7 year old sample contained 221,280 children (from 3,167 schools, 75 centres, 32
countries). There were 120,799 children (from 2,165 schools, 59 centres, 22 countries) with
complete data across all analysis variables. See the data flowchart (Figure 1) for further
details. Individual- and school-level summary statistics are presented in Table 1 for the
“common sample” and Table S1 (Supplementary Material) for the “maximum sample” (see
“Statistical analyses” section for definitions).
Minimally adjusted associations in the common sample were broadly similar to those in the
maximum sample (Tables 2 and S3). The strongest associations in the fully-adjusted
individual-level analyses were for current paracetamol use (odds ratio (OR) = 1.45, 95%CI
1.37-1.54), antibiotic use in the first year of life (1.41, 1.34-1.48), and paracetamol use in the
first year of life (1.28, 1.21-1.36) (Table 2).
In fully-adjusted school-level analyses, the associations for current paracetamol use (1.55,
1.10-2.21) and early life antibiotic use (1.35, 1.00-1.82) were maintained, but the association
with early life paracetamol use disappeared (0.94, 0.69-1.28) (Table 2). Stronger associations
were observed at school-level for open fire cooking (1.84, 0.98-3.45 compared to 1.12, 0.95-
1.32 at individual-level), and maternal tobacco use (1.61, 1.14-2.25 compared to 1.06, 0.99-
1.13 at individual-level). A weak association with current heavy traffic exposure observed at
individual-level was no longer significant at school level. Associations with breastfeeding
were similar in individual and school-level analyses (1.11, 1.05-1.18 and 1.06, 0.75-1.48) but
with less precision. A potentially harmful association of low birthweight with AE symptoms
was seen at school-level (1.78, 1.07-2.95) compared to a small protective association at
individual-level (0.89, 0.81-0.97) (Table 2).
9In analyses stratified by country-level affluence (Tables S4-S5, Supplementary Material),
there was strong evidence at individual-level that being exposed to a cat, dog or farm animals
in the first year of life, or maternal contact with farm animals while pregnant, was associated
with AE symptoms in non-affluent countries at individual level (Tables S4 and S5), while
none of these associations were observed at school-level in either setting. There was also
evidence that the association of AE symptoms with current paracetamol was strong at
individual and school-level with stronger estimates in affluent countries (1.64; 1.49-1.79)
than non-affluent settings (1.35, 1.25-1.45). Weak associations with breastfeeding were only
observed at individual-level in affluent countries, but were not observed at school-level, with
no association being seen in non-affluent countries.
13-14 year olds
The full 13-14 year old sample contained 362,048 adolescents (from 2,592 schools, 122
centres, 54 countries). There were 233,159 adolescents (from 2,039 schools, 97 centres, 41
countries) with complete data across all analysis variables. See the data flowchart (Fig. 2) for
further details. Individual- and school-level summary statistics are presented in Table 1 for
the common sample and Table S1 (Supplementary Material) for the maximum sample.
Minimally adjusted associations in the common sample were broadly similar to those in the
maximum sample (Tables 2 and S3). The strongest associations in fully-adjusted individual-
level analyses were for current paracetamol use (1.57, 1.51-1.63), cooking on an open fire
(1.46, 1.33-1.62), and exposure to heavy truck traffic (1.31, 1.27-1.36) (Table 2).
In fully-adjusted school-level analyses associations for current paracetamol use (2.57, 1.84-
3.59), cooking on an open fire (2.38, 1.52-3.73) and heavy truck traffic (1.40, 1.07-1.82) were
maintained (Table 2). An association was also observed at school-level for fast food
consumption (2.11, 1.66-2.70) with a much weaker association at individual-level (1.05,
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1.02-1.10). At individual-level there was an association with paternal tobacco use (1.15, 1.10-
1.19), with conflicting findings at school-level (0.64, 0.44-0.94).
In analyses stratified by country-level affluence (Tables S4-S5, Supplementary Material)
there was evidence at individual-level that current paracetamol use was slightly more strongly
associated with AE symptoms in affluent (1.75, 1.60-1.92) than non-affluent (1.53, 1.47-
1.60) countries (Table S4), with stronger associations in both settings at school-level (Table
S5). There was also some evidence that paternal tobacco use was associated with AE
symptoms in non-affluent countries (1.17, 1.12-1.23) at individual-level, but not at school-
level, and no association was seen in affluent settings (1.05, 0.96-1.14).
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DISCUSSION
This study is the first comprehensive analysis of key risk factors for childhood AE, analysed
together in a multivariable regression analysis, at individual (child) level to find which
variables were the most important, and community (school) level to find which ones
remained important. The school was the sampling unit, so analyses using school-level
prevalence of exposures offer novel insights into the possible extent of bias due selective
avoidance or confounding by indication. These forms of reverse causation, which are a
particular issue in cross-sectional analyses, are less of an issue using school-level exposures
rather than individual-level exposures. When comparing school-level and individual-level
findings, if confounding by indication was a major issue, associations would be weaker at
school-level, whereas if selective avoidance was the source of reverse causation, associations
at the school-level would appear more harmful. Consistent findings between school and
individual-level analyses suggest that neither of the two forms of reverse causation explain
the findings. In contrast, school-level analyses are prone to ecologic (population level)
confounding, which is not an issue when using the individual-level approach. Given that the
individual- and school-level analyses will potentially be affected in different ways by reverse
causation and confounding by indication, we consider it is sensible to fit regression models at
each level (child within school and school within centre) and compare the results to assess
robustness to different interpretations, rather than considering one approach more appropriate
than the other. The analyses use the data from ISAAC Phase Three, where many individual-
level single risk factor analyses found associations, but some of these were not corroborated
in the present analyses.
6-7 year olds
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The 6-7 year old results from the present study are summarised and compared with previous
ISAAC analyses in Table 3, along with an assessment of potential bias and an outline of the
biological plausibility of the effect.
The strongest associations for 6-7 year olds in individual-level analyses were for current
paracetamol use, and antibiotic and paracetamol use in the first year of life. However in
school-level analyses, only associations with current paracetamol persisted. These school-
level findings provide evidence against reverse causation, including confounding by
indication, as an explanation, and thus make a causal link more likely. Associations between
AE and current paracetamol use are consistent with those from individual-level single risk
factor analyses in previous ISAAC Phase Three publications, which reported dose-response
relationships between the quantity of paracetamol taken in the previous year and current AE
symptoms (medium 1.18 (1.08-1.30) and high 1.87 (1.68-2.08) compared to no paracetamol)
(Beasley et al., 2008). Possible biological mechanisms underlying the observed association
between paracetamol use and AE may relate to a depletion of glutathione in antigen
presenting cells resulting in a shift from a Th1 to a predominantly Th2 immune response.
(Beasley et al., 2008, Beasley et al., 2011, Peterson et al., 1998)
Associations with early antibiotic use persisted after adjusting for confounders and were also
observed in school-level analyses, although this association was weaker, suggesting that
confounding by indication may partly contribute to the association, but does not completely
explain it. Findings are consistent with those observed in individual-level single risk factor
analyses (1.42 (1.33-1.51)) in previous ISAAC Phase Three publications (Foliaki et al.,
2009). In our further analyses, stratifying by affluence, similar associations with early
antibiotic use were observed in affluent and non-affluent countries. The reasons for this
association with antibiotics and potential causality are unclear, with proposed theories
including changes in the gut microbiome.(Tsakok et al., 2013)
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Breastfeeding was associated with a slightly increased risk of AE at individual-level with
similar but weaker results at school-level. The individual-level association was strongest in
affluent countries but was not significant at school level (Tables S4 and S5). These
observations reflect previous reports when assessing breastfeeding as an individual-level
exposure in ISAAC Phase Three data (1.05, 0.97-1.12) (Bjorksten et al., 2011). Our findings
do not support the reverse causation theory that in affluent countries those children at highest
risk of developing AE are more likely to be breastfed (Bjorksten et al., 2011, Yang et al.,
2009).
We observed evidence of a weak protective effect of low birthweight in individual-level
analyses in contrast to a potentially harmful effect in school-level analyses. Individual-level
findings are consistent with the previous ISAAC individual-level single risk factor analyses;
although additionally these analyses showed no association between birthweight and AE
severity and the importance of the finding from a public health perspective was not clear
(Mitchell et al., 2014). It is possible that the opposite school-level association may indicate
residual socio-economic confounding at community level as schools with a high proportion
of low birthweight children may be in more deprived areas (Dibben et al., 2006).
We also observed weak evidence in individual-level analyses that current AE was slightly
more common in children exposed to cats, dogs and farm animals in the first year of life.
There were similar results at school-level. In stratified analyses all of these associations were
restricted only to non-affluent settings, where there is likely to be less awareness of these
associations with AE, making bias or differential recall of exposure less likely explanations.
Findings for these combined analyses of the ISAAC Phase Three data are consistent with
those observed in individual-level single risk factor analyses (Brunekreef et al., 2012a,
Brunekreef et al., 2012b).
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Current heavy traffic exposure was associated with a weak increased risk of AE symptoms in
individual-level but not school-level analyses. A possible explanation for the differential
associations at individual-level and school-level relates to bias; perhaps parents of individuals
with current AE symptoms are more concerned about heavy traffic exposure and more likely
to report it compared to those without symptoms. These findings may help interpret the
similar associations observed in previous individual-level single risk factor analyses
(Brunekreef et al., 2009).
13-14 year olds
The 13-14 year old results from the present study are summarised and compared with
previous ISAAC analyses in Table 4, along with an assessment of potential bias and an
outline of the biological plausibility of the effect.
The strongest association with current AE in adolescents at individual-level was with current
paracetamol use, with even stronger potentially harmful associations observed at school-
level. The stronger school-level associations suggest that reverse causation is unlikely to
explain these associations, although ecological confounding, whereby confounding arises due
to within-area heterogeneity of exposures, is possible. Findings are consistent with previous
individual-level single risk factors analyses (Beasley et al., 2011).
Using open fires for cooking was more strongly associated with current AE symptoms at
school-level compared to individual-level, findings which could be partially attributed to
avoidance behaviour in parents of children with current AE (Wong et al., 2013). The
association with AE observed at individual-level at age 13-14 years with no association at age
6-7 years is consistent with previous single exposure ISAAC studies.(Wong et al., 2013)
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Strong potentially harmful associations with AE symptoms were seen for current heavy
traffic exposure at individual-level and school-level. This is in contrast to the younger age-
group; a possible explanation is that persistent AE may be more severe and more likely to
react to aeroallergens and irritants. Individual-level analyses demonstrated similar
associations with a dose-response relationship between levels of exposure to traffic and AE
symptoms.(Brunekreef et al., 2009)
Though weak associations were observed at individual-level with current maternal and
paternal tobacco exposure, at school-level the effect was reversed with weak evidence of a
protective effect for paternal smoking. This finding might support differential reporting of
tobacco exposure in those with current AE symptoms or ecologic bias at school level
(Mitchell et al., 2012).
Strong associations were observed at school-level with fast food consumption, with very
weak associations being observed at individual-level. Findings are consistent with previous
individual-level single risk factor analyses and might plausibly be important for the aetiology
of AE, although ecologic bias and residual confounding are alternative possibilities (Ellwood
et al., 2001, Ellwood et al., 2013).
Weak associations were observed between having two or more siblings and current AE
symptoms at an individual-level with slightly stronger associations at school-level (but with
weaker precision). Findings are not consistent with those observed at age 6-7 years of age,
are in contrast to protective associations reported in individual-level single risk factor
analyses, and may represent a chance association (Strachan et al., 2015).
Strengths and limitations of the study
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The ISAAC study had worldwide coverage and a very large sample size, including countries
from less affluent settings, thus facilitating the study of environmental factors in varied
settings (Odhiambo et al., 2009). The use of standardised and validated methods of symptoms
reporting is a particular strength of the ISAAC study (Flohr et al., 2009). Although self-
reported symptoms may be prone to misclassification, they avoid major diagnostic
differences due to access to care in different countries and settings, where relying on doctor
diagnosis may be more problematic. Selection bias is an unlikely explanation for the findings
as response rates of the children were high (85%).
Assessment of exposures was based on parental or guardian (6-7 year old children) and study
participant (13-14 year old adolescents) completion of questionnaires about historical
exposures rather than objective measures, leading to possible misclassification, which for
different exposures may be non-differential or may be prone to recall biases or reverse
causation. Schools were the sampling unit, with individual children of the age group
responding within the school, and this structure of the cross-sectional survey enabled these
analyses.
Both individual-level and school-level analyses may be biased by residual confounding by
factors that were either imperfectly measured or not measured at all; however, as the
unmeasured confounders are likely to be different at school and individual level, consistency
of findings at both levels is reassuring against associations being due to residual confounding.
Conclusions
We have further enhanced the ISAAC analyses by using school-level as well as individual-
level exposures, thus allowing us to explore whether specific findings may be due to reverse
causation, including confounding by indication. Despite plausible mechanisms, we did not
observe findings supportive of selective avoidance in relation to furry pet exposure. The
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consistent associations between current paracetamol exposure in both age groups and at both
individual and school-level argues against reverse causation as the sole explanation. The
consistent associations between current paracetamol exposure in both age groups and at both
individual and school-level argues against reverse causation as the sole explanation. If
paracetamol use in early childhood does have a direct biological role in the development of
atopic eczema and related disorders such as asthma, then reducing paracetamol use in infancy
could reduce the incidence of such diseases. Indeed, a randomised controlled prevention trial
in New Zealand called PIPPA Tamariki (ACTRN12618000303246) that seeks to determine
whether ibuprofen instead of paracetamol for fever/pain in infancy reduces the incidence of
asthma and eczema, is already underway.
Some individual-level single risk factor associations previously identified in ISAAC Phase
Three data were not corroborated in the present analyses, but several were: current
paracetamol use at ages 6-7 and 13-14, early life antibiotic exposure and AE at age 6-7, and
current heavy road traffic and open fire cooking and AE symptoms at 13-14 years. The novel
approach of using school-level exposure estimates provides insight that some of the
previously reported associations in ISAAC Phase Three studies may be due to reverse
causation, but that paracetamol use is unlikely to be explained in this way.
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MATERIAL AND METHODS
Study
A detailed description of the ISAAC Phase Three methods can be found elsewhere (Ellwood
et al., 2005), and they will be briefly summarized here. ISAAC Phase Three is a multi-centre,
multi-country, cross-sectional study of two age groups of schoolchildren (6-7 year old
children and 13-14 year old adolescents) chosen from a random sample of schools in a
defined geographical area (Asher et al., 1995). The Phase Three survey included a
standardised symptom questionnaire, which obtained data on symptoms of asthma,
rhinoconjunctivitis and AE (Asher et al., 1995). It also included a supplementary
questionnaire which obtained data on a wide range of possible risk factors for the
development of allergic disorders (Beasley et al., 2008). Parents or guardians completed the
questionnaires for 6-7 year olds and 13-14 year olds answered the questionnaires themselves
(http://isaac.auckland.ac.nz). Centre eligibility is described in the supplementary methods.
Variables
The outcome of interest, AE symptoms in the last 12 months, was defined by positive
responses to the questions “Has your child/have you ever had an itchy rash which was
coming and going for at least six months?”, “Has your child/have you had this itchy rash at
any time in the last 12 months?” and “Has this itchy rash at any time affected any of the
following places: the folds of the elbows, behind the knees, in front of the ankles, under the
buttocks, or around the neck, ears or eyes?”.
Analyses in this paper included only the key environmental variables previously each singly
associated with AE in ISAAC at an individual-level. Full definitions of the environmental
risk factors are in Table S2 of the Supplementary Material.
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Additionally, the analysis considered confounding by sex and highest level of maternal
education (primary, secondary, tertiary, missing/not stated).
Finally, stratification by affluence of country was achieved using standard approaches (see
Supplementary methods).
Statistical analyses
The two age groups were analysed separately. All analyses were conducted using mixed
effect logistic regression models. There are four hierarchies of data in the study design:
individual, school, centre and country. We accounted for this by including random intercepts
at each of the higher 3 levels. Sex and highest level of maternal education were adjusted for
as individual-level confounders in all models. The school-level prevalence of each risk factor
was calculated as the proportion of children with that risk factor out of all children included
in the analysis within that school.
Separate models were used to assess the effects of individual-level exposures and aggregated
school-level prevalence of exposures on the individual-level outcome. Using the approach
proposed by (Begg and Parides, 2003), these effects were formally compared within a multi-
level framework, by fitting “hybrid fixed effect models”. Results from these models were
consistent with a simpler approach and are not discussed further.
Within each of these approaches, a minimally adjusted model was fitted. This was done on
two samples (i) the “maximum sample” which was the sub-sample that had no data missing
for AE, the confounders (sex, level of maternal education) and the one exposure of interest
(ii) the “common sample” which was the sub-sample that had no data missing for AE,
confounders and all exposures of interest. A fully adjusted model was also fitted to the
common sample. Fully adjusted models included all risk factors at the individual level for the
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individual-level models, school-level prevalence of all the risk factors for the school-level
models.
The extent of co-linearity in fully adjusted models was examined by comparing the standard
errors in the fully adjusted model with the standard errors in the minimally adjusted model
(common sample). Fully adjusted analyses were additionally stratified by ‘affluent’ and ‘non-
affluent’ countries to assess whether avoidance behaviour may have contributed to observed
associations (since such behaviour is more likely in more affluent countries). Effect
modification by country-level affluence was tested for each risk factor separately.
All analyses were conducted using Stata version 14.2 (StataCorp, 2015). Informed consent
was obtained from parents of all participating children; the ISAAC Phase Three study was
approved by local institutional review boards in all participating centres.
21
CONFLICT OF INTEREST
We would like to acknowledge and thank the many funding bodies throughout the world that
supported the individual ISAAC centres and collaborators and their meetings. In particular,
we wish to thank the London School of Hygiene and Tropical Medicine, and the United
Kingdom Medical Research Council for supporting the work involved in the current paper.
We also wish to thank the Health Research Council of New Zealand, the Asthma and
Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke’s
Bay Medical Research Foundation, the Waikato Medical Research Foundation, Glaxo
Wellcome New Zealand, the NZ Lottery Board and Astra Zeneca New Zealand. Glaxo
Wellcome International Medical Affairs, supported the Regional Coordination and the
ISAAC International Data Centre (IIDC). Charlotte Rutter is funded by the Medical Research
Council [grant number MR/N013638/1]. Dr Langan is funded by a Wellcome Senior
Fellowship in Clinical Science (205039/Z/16/Z). Professor Pearce is funded by a European
Research Council Advanced grant. Without help from all of the above, ISAAC would not
have given us all these results from so many countries.
ACKNOWLEDGMENTS
We are grateful to the children and parents who willingly participated and cooperated in
ISAAC Phase Three and the coordination and assistance by the school staff is sincerely
appreciated. We thank the Phase Three National Coordinators, Principal Investigators and
their colleagues, who helped make ISAAC Phase Three such a success.
ISAAC Phase Three Study Group
ISAAC Steering Committee: N Aït-Khaled* (Union Internationale Contre la Tuberculose et
les Maladies Respiratoires, Paris, France); HR Anderson (Department of Public Health
Sciences, St Georges Hospital Medical School, London, UK); MI Asher (Department of
Paediatrics: Child and Youth Health, The University of Auckland, New Zealand); R Beasley*
(Medical Research Institute of New Zealand, Wellington, New Zealand); B Björkstén*
(Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden); B
Brunekreef (Institute of Risk Assessment Science, Universiteit Utrecht, Netherlands); J Crane
(Wellington Asthma Research Group, Wellington School of Medicine, New Zealand); P
22
Ellwood (Department of Paediatrics, Faculty of Medical and Health Sciences, The University
of Auckland, New Zealand); C Flohr (Centre for Evidence Based Dermatology, Queen’s
Medical Centre, University Hospital, Nottingham, UK); F Forastiere (Department of
Epidemiology, Rome E Health Authority, Italy); L García-Marcos (Instituto de Salud
Respiratoria, Universidad de Murcia, Spain); S Foliaki* (Centre for Public Health Research,
Massey University, Wellington, New Zealand); U Keil* (Institut für Epidemiologie und
Sozialmedizin, Universität Münster, Germany); CKW Lai* (Department of Medicine and
Therapeutics, The Chinese University of Hong Kong, SAR China); J Mallol* (Department of
Respiratory Medicine, University of Santiago de Chile, Chile); CF Robertson (Murdoch
Children’s Research Institute, Melbourne, Australia); EA Mitchell (Department of
Paediatrics, Faculty of Medical and Health Sciences, The University of Auckland, New
Zealand); S Montefort* (Department of Medicine, University of Malta, Malta), J
Odhiambo†* (Centre Respiratory Diseases Research Unit, Kenya Medical Research Institute,
Nairobi, Kenya); N Pearce (Centre for Public Health Research, Massey University,
Wellington, New Zealand); J Shah* (Jaslok Hospital & Research Centre, Mumbai, India);
AW Stewart (Population Health, Faculty of Medical and Health Sciences, The University of
Auckland, New Zealand); D Strachan (Department of Public Health Sciences, St Georges
Hospital Medical School, London, UK); E von Mutius (Dr von Haunerschen Kinderklinik de
Universität München, Germany); SK Weiland† (Department of Epidemiology, University of
Ulm, Germany); G Weinmayr (Institute of Epidemiology, University of Ulm, Germany); H
Williams (Centre for Evidence Based Dermatology, Queen’s Medical Centre, University
Hospital, Nottingham, UK); G Wong (Department of Paediatrics, Prince of Wales Hospital,
Hong Kong, SAR China). *Regional Coordinators. †Deceased.
ISAAC International Data Centre: MI Asher, TO Clayton†, E Ellwood, P Ellwood, EA
Mitchell, Department of Paediatrics: Child and Youth Health, and AW Stewart, School of
Population Health, Faculty of Medical and Health Sciences, The University of Auckland,
New Zealand. †Deceased
ISAAC Principal Investigators: Argentina: Dr CE Baena-Cagnani*†, Catholic University of
Córdoba (Córdoba), Dr M Gómez, Ayre Foundation; Hospital San Bernardo (Salta);
23
Barbados: Dr ME Howitt*, Carlton Clinic (Barbados); Belgium: Professor J Weyler,
University of Antwerp (Antwerp); Bolivia: Dra R Pinto-Vargas*, Caja Petrolera de Salud
(Santa Cruz), Associate Professor L de Freitas Souza, Universidade Federal da Bahia (Feira
de Santana, Vitória da Conquista, Salvador); Brasil: Professor AJLA Cunha, Federal
Universtity of Rio de Janeiro (Nova Iguaçu), Cameroon: Professor C Kuaban*, University of
Yaounde (Yaounde); Canada: Professor A Ferguson, University of British Columbia
(Vancouver), Professor D Rennie, University of Saskatchewan (Saskatoon); Channel
Islands: Dr P Standring, Princess Elizabeth Hospital (Guernsey); Chile: Dr P Aguilar,
Hospital CRS El Pino (South Santiago), Dr L Amarales, Regional Hospital "Lautaro
Navarro" (Punta Arenas), Dr LAV Benavides, (Calama), Dra A Contreras, Hospital de
Castro (Chiloe); China: Professor Y-Z Chen*, Training Hospital for Peking University
(Beijing, Tong Zhou), Professor N-S Zhong, Guangzhou Institute of Respiratory Disease
(Guangzhou), Assistant Professor O Kunii, University of Tokyo (Tibet), Dr Q Li Pan,
Xinjiang Children's Hospital (Wulumuqi); Colombia: Dr G Aristizábal, Instituto de
Enfermedades Respiratorias del Niño S.A. (Bogotá), Dr AM Cepeda, Universidad
Metropolitana (Barranquilla), Dr GA Ordoñez, Universidad Libre de Cali (Cali); Cote
d’Ivoire: Dr BN Koffi*, (Urban Cote d Ivoire); Ecuador: Dr C Bustos, Hospital Alcivar
(Guayaquil); Estonia: Dr M-A Riikjärv*, Tallinn Children's Hospital (Tallinn); Ethiopia:
Associate Professor K Melaku, Addis Ababa University (Addis Ababa); Fiji: Dr R Sa'aga-
Banuve, UNICEF (Suva); Finland: Dr J Pekkanen*, National Public Health Institute
(Kuopio County); Former Yugoslav Republic of Macedonia: Associate Professor E
Vlaski*, University Children's Clinic (Skopje); Gabon: Dr IE Hypolite*, (Port-Gentil);
Hong Kong (SAR China): Professor G Wong, Prince of Wales Hospital (Hong Kong 13-
14); Hungary: Dr Z Novák*, University of Szeged (Szeged), Dr G Zsigmond, Senior
Consultant (Svábhegy); India: Professor S Awasthi, King George's Medical University
(Lucknow), Associate Professor S Bhave, KEM Hospital Research Centre (Rasta Peth), Dr
NM Hanumante, Ruby Hall Clinic (Pune), Dr KC Jain, Pioneer Medical Centre (Jodhpur), Dr
MK Joshi, Panjat Hospital (Mumbai (16)), Dr SN Mantri, Jaslok Hospital & Research Centre
(Mumbai (29)), Dr AV Pherwani, P.D. Hinduja Hospital and Medical Research Centre
(Mumbai (18)), Professor S Rego, St John`s Medical College & Hospital (Bangalore), Dr S
Salvi, Chest Research Foundation (Nagpur, Pimpri), Professor SK Sharma, All India Institute
of Medical Sciences (New Delhi (7)), Professor V Singh, Asthma Bhawan (Jaipur), Dr T
Sukumaran, PIMS Thiruvalla (Kottayam), Dr VA Khatav, Dr Khatav's Mother and Child
Hospital (Borivali), Dr G Setty, (Chennai), Professor M Sabir, Senior Consultant Physician
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& Pulmonologist, Kothari Medical & Research Institute (KMRI), (Bikaner); Indonesia: Prof
Dr CB Kartasasmita, Padjajaran University (Bandung), Professor P Konthen†, Airlangga
University (Bali), Dr W Suprihati, Diponegoro University (Semarang); Iran: Dr M-R
Masjedi*, National Research Institute of Tuberculosis and Lung Diseases (Rasht, Tehran);
Isle Of Man: Dr A Steriu, Public Health Specialist, Information and Research (Isle of Man);
Kuwait: Dr JA al-Momen, Al-Amiri Hospital (Kuwait); Kyrgyzstan: Dr C Imanalieva*,
Kyrgyz Scientific Research Institute of Obstetrics and Pediatrics (Balykchi, Bishkek);
Lithuania: Associate Professor J Kudzyte*, Kaunas Medical University (Kaunas);
Malaysia: Professor BS Quah, Melaka-Manipal Medical College, (Kota Bharu), Dr KH Teh,
Hospital Alor Setar (Alor Setar); Malta: Professor S Montefort*, University of Malta
(Malta); Mexico: Dr M Baeza-Bacab*, University Autónoma de Yucatán (Mérida), Dra N
Ramírez-Chanona, COMPEDIA (Ciudad de México (4)), Dra M Barragán-Meijueiro,
CoMAAIPE (Ciudad de México (3)), Dra BE Del-Río-Navarro, Hospital Infantil de México
(Ciudad de México (1)), Dr R García-Almaráz, Hospital Infantil de Tamaulipas (Ciudad
Victoria), Dr SN González-Díaz, Hospital Universitario (Monterrey), Dr FJ Linares-Zapién,
Centro De Enfermedades Alergicas Y Asma de Toluca (Toluca), Dr JV Merida-Palacio,
Centro de Investigacion de Enfermedades Alergicas y Respiratorias (Mexicali Valley), Dr S
Romero-Tapia, Hospital de Alta Especialidad del Niño (Villahermosa), Professor I Romieu,
International Agency for Research on Cancer (Cuernavaca); Morocco: Professor Z
Bouayad*, Service des Maladies Respiratoires (Boulmene, Casablanca, Marrakech); New
Zealand: Professor MI Asher*, University of Auckland (Auckland), Dr R MacKay,
Canterbury Health Laboratories (Nelson), Dr C Moyes, Whakatane Hospital (Bay of Plenty),
Associate Professor P Pattemore, University of Otago, Christchurch (Christchurch), Professor
N Pearce, London School of Hygiene and Tropical Medicine (Wellington); Nigeria:
Professor BO Onadeko, (Ibadan); Panamá: Dr G Cukier*, Hospital Materno Infantil Jose
Domingo de Obaldia (David-Panamá); Peru: Dr P Chiarella*, Universidad Peruana de
Ciencias Aplicadas, UPC (Lima); Philippines: Professor F Cua-Lim*†, University of Santo
Tomas (Metro Manila); Poland: Associate Professor A Brêborowicz, University of Medical
Sciences (Poznan), Associate Professor G Lis*, Jagiellonian University (Kraków); Portugal:
Dra R Câmara, Centro Hospitilar do Funchal (Funchal), Dr JM Lopes dos Santos, Hospital
Pedro Hispano (Porto), Dr C Nunes, Center of Allergy and Immunology of Algarve
(Portimao), Dr J Rosado Pinto*, Hospital da Luz (Lisbon), Dr ML Chiera, Hosp. Ped.
Coimbra (Coimbra); Samoa: Ms P Fuimaono V Pisi, (Apia); Singapore: Associate
Professor DY Goh, National University of Singapore (Singapore); South Africa: Professor
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HJ Zar*, University of Cape Town (Cape Town); South Korea: Professor H-B Lee*,
Hanyang University College of Medicine (Provincial Korea, Seoul); Spain: Professor A
Blanco-Quirós, Facultad de Medicina (Valladolid), Dr RM Busquets, Universidad Autonoma
de Barcelona (Barcelona), Dr I Carvajal-Urueña, Centro de Salud de La Ería (Asturias), Dr G
García-Hernández, Hospital Universitario 12 de Octubre (Madrid), Professor L García-
Marcos*, University of Murcia and IMIB-Arrxaca Research Institute (Cartagena), Dr C
González Díaz, Universidad del País Vasco UPV /EHU (Bilbao), Dr A López-Silvarrey
Varela, Fundacion Maria Jose Jove (A Coruña), Professor M Morales-Suárez-Varela,
Valencia University-CIBERESP (Valencia), Professor EG Pérez-Yarza, Universidad del Pais
Vasco UPV/EHU (San Sebastián); Sudan: Prof OA Musa, National Ribat University
(Khartoum); Sultanate Of Oman: Professor O Al-Rawas*, Sultan Qaboos University (Al-
Khodh); Syrian Arab Republic: Professor Y Mohammad, National Center for Research and
Training in Chronic Respiratory Diseases - Tishreen University (Lattakia), Dr S
Mohammad*, Tishreen University (Tartous), Dr K Tabbah, Aleppo University Hospital
(Aleppo); Taiwan: Dr J-L Huang*, Chang Gung University (Taipei), Dr C-C Kao, Kao-
Chun-Chieh Clinic (Taoyuan); Thailand: Associate Professor M Trakultivakorn, Chiang Mai
University (Chiang Mai), Dr P Vichyanond*, Mahidol University (Bangkok); Tokelau: Dr T
Iosefa*, Ministry of Health (Tokelau); United Kingdom: Dr M Burr†, Cardiff University
Neuadd Meirionnydd (Wales), Professor D Strachan, Population Health Research Institute, St
George’s, University of London (Surrey/Sussex); Uruguay: Dra D Holgado*, Hospital
Pereira Rossell (Montevideo), Dra MC Lapides, Hospital Paysandú (Paysandú); Usa: Dr HH
Windom, Asthma and Allergy Research Center (Sarasota); Venezuela: Dr O Aldrey*, Jefe
del Instituto (Caracas).
* National Coordinator, †Deceased
ISAAC National Coordinators not identified above: Brazil: Prof D Solé, Universidade
Federal de São Paulo; Canada: Prof M Sears, McMaster University; Chile: Dra V Aguirre,
Hospital CRS El Pino; Ecuador: Dr S Barba, AXXIS-Medical Centre SEAICA; Sar China:
Dr CK Lai, The Chinese University of Hong Kong; India: Dr J Shah, Jaslok Hospital &
Research Centre; Indonesia: Prof Dr K Baratawidjaja, University of Indonesia; Malaysia:
Assoc Prof J de Bruyne, University of Malaya; Samoa: Dr N Tuuau-Potoi, Ministry of
Health, Samoa; Singapore: Prof B Lee, National University Hospital; Sudan: Dr A El Sony,
Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development; United
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Kingdom, Channel Islands, Isle of Man: Prof R Anderson, St George's, University of
London.
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Table 1: Summary statistics in subjects with data for atopic eczema symptoms, sex, maternal education and all exposures of interest (the “common
sample”).
Age group Variable Individual-level (n = 120,799) School-level (n = 2,165)
Prevalence Median prevalence Prevalence IQR
6-7 years
AE in the last 12 months 0.074 0.064 (0.021, 0.120)
Farm animals (in utero) 0.077 0.066 (0.023, 0.127)
Low birthweight 0.077 0.056 (0.022, 0.097)
Paracetamol (1st year) 0.662 0.707 (0.571, 0.843)
Antibiotics (1st year) 0.557 0.571 (0.472, 0.654)
Breastfed ever 0.805 0.837 (0.735, 0.918)
Cat (1st year) 0.109 0.083 (0.036, 0.167)
Dog (1st year) 0.198 0.197 (0.100, 0.307)
Farm animals (1st year) 0.094 0.083 (0.037, 0.148)
2 or more siblings 0.347 0.328 (0.185, 0.484)
Heavy Truck traffic (current) 0.380 0.378 (0.270, 0.487)
Fast food (current) 0.396 0.311 (0.165, 0.500)
Paternal tobacco (current) 0.318 0.348 (0.211, 0.478)
Maternal tobacco (current) 0.163 0.167 (0.044, 0.328)
Paracetamol (current) 0.180 0.142 (0.061, 0.250)
Open fire cooking (current) 0.019 0.000 (0.000, 0.016)
Age group Variable Individual-level (n = 233,159) School-level (n = 2,039)
Prevalence Median prevalence Prevalence IQR
13-14 years
AE in the last 12 months 0.062 0.048 (0.022, 0.091)
2 or more siblings 0.541 0.593 (0.377, 0.800)
Heavy Truck traffic (current) 0.396 0.392 (0.301, 0.500)
Fast food (current) 0.536 0.528 (0.391, 0.680)
Paternal tobacco (current) 0.384 0.371 (0.238, 0.490)
Maternal tobacco (current) 0.183 0.185 (0.036, 0.354)
Paracetamol (current) 0.270 0.298 (0.177, 0.417)
Open fire cooking (current) 0.052 0.006 (0.000, 0.029)
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Table 2. Effects of individual- and school-level exposures on atopic eczema symptoms in the last 12 months in subjects with data for atopic eczema
symptoms, sex, maternal education and all exposures of interest (the “common sample”). Mixed logistic regression models with random intercepts at
the school, centre and country levels.
Age group Exposure Individual-level exposure School-level exposure
Minimally adjustedA Fully adjustedB Minimally adjustedA Fully adjustedB
6-7 years
(n = 120,799)
Farm animals (in utero) 1.32 (1.22, 1.43) 1.11 (1.00, 1.23) 1.48 (1.04, 2.12) 1.05 (0.54, 2.04)
Low birthweight 0.92 (0.84, 1.01) 0.89 (0.81, 0.97) 2.32 (1.43, 3.76) 1.78 (1.07, 2.95)
Paracetamol (1st year) 1.53 (1.45, 1.61) 1.28 (1.21, 1.36) 1.11 (0.85, 1.46) 0.94 (0.69, 1.28)
Antibiotics (1st year) 1.56 (1.49, 1.64) 1.41 (1.34, 1.48) 1.32 (1.00, 1.75) 1.35 (1.00, 1.82)
Breastfed ever 1.09 (1.03, 1.16) 1.11 (1.05, 1.18) 0.97 (0.69, 1.35) 1.06 (0.75, 1.48)
Cat (1st year) 1.17 (1.10, 1.25) 1.10 (1.03, 1.17) 1.40 (0.99, 1.97) 1.15 (0.78, 1.71)
Dog (1st year) 1.12 (1.07, 1.18) 1.05 (1.00, 1.11) 1.20 (0.90, 1.61) 0.96 (0.69, 1.32)
Farm animals (1st year) 1.32 (1.23, 1.42) 1.16 (1.06, 1.27) 1.50 (1.07, 2.10) 1.15 (0.62, 2.15)
2 or more siblings 0.96 (0.91, 1.01) 0.95 (0.90, 0.99) 1.26 (1.01, 1.56) 1.11 (0.88, 1.40)
Heavy Truck traffic (current) 1.16 (1.11, 1.22) 1.11 (1.06, 1.16) 0.92 (0.74, 1.14) 0.81 (0.65, 1.02)
Fast food (current) 1.03 (0.98, 1.08) 0.99 (0.94, 1.04) 0.94 (0.75, 1.18) 0.96 (0.76, 1.22)
Paternal tobacco (current) 1.08 (1.03, 1.13) 1.04 (0.99, 1.10) 1.18 (0.92, 1.53) 0.83 (0.61, 1.13)
Maternal tobacco (current) 1.10 (1.04, 1.17) 1.06 (0.99, 1.13) 1.56 (1.18, 2.07) 1.61 (1.14, 2.25)
Paracetamol (current) 1.60 (1.51, 1.69) 1.45 (1.37, 1.54) 1.63 (1.17, 2.26) 1.55 (1.10, 2.21)
Open fire cooking (current) 1.15 (0.97, 1.35) 1.12 (0.95, 1.32) 2.30 (1.27, 4.16) 1.84 (0.98, 3.45)
Age group Exposure Individual-level exposure School-level exposure
Minimally adjustedA Fully adjustedB Minimally adjustedA Fully adjustedB
13-14 years
(n = 233,159)
2 or more siblings 1.10 (1.05, 1.14) 1.08 (1.03, 1.12) 1.34 (1.04, 1.74) 1.26 (0.97, 1.65)
Heavy Truck traffic (current) 1.36 (1.31, 1.41) 1.31 (1.27, 1.36) 1.66 (1.28, 2.17) 1.40 (1.07, 1.82)
Fast food (current) 1.10 (1.05, 1.14) 1.05 (1.02, 1.10) 2.08 (1.63, 2.66) 2.11 (1.66, 2.70)
Paternal tobacco (current) 1.21 (1.16, 1.25) 1.15 (1.10, 1.19) 0.85 (0.61, 1.17) 0.64 (0.44, 0.94)
Maternal tobacco (current) 1.19 (1.14, 1.25) 1.11 (1.06, 1.16) 0.72 (0.50, 1.04) 0.79 (0.52, 1.19)
Paracetamol (current) 1.61 (1.55, 1.67) 1.57 (1.51, 1.63) 2.68 (1.91, 3.75) 2.57 (1.84, 3.59)
Open fire cooking (current) 1.47 (1.33, 1.62) 1.46 (1.33, 1.62) 2.29 (1.47, 3.57) 2.38 (1.52, 3.73)
AAdjusted for sex and mothers level of education. BAdditionally adjusted for all other variables in the table.
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Table 3. Associations between eczema symptoms in the last 12 months and risk factors for 6-7 year old age group comparing results from different
analyses
Exposure
Current analysis Previous ISAAC analysis Assessment of
bias
Biological
plausibility of effectIndividual
levela
School levelb Comparison Individual levelc
Comparison with
current analysis
Farm
animals (in
utero)
1.11 (1.00,
1.23)
1.05 (0.54,
2.04)
No association at
school level
1.17 (1.07,1.29)
(Brunekreef et al.,
2012b)
Consistent No evidence of
reverse causation
bias
Not observed at
school level
Low
birthweight
0.89 (0.81,
0.97)
1.78 (1.07,
2.95)
Individual shows
a protective effect
but school level is
harmful
0.93 (0.85, 1.01)
(Mitchell et al., 2014)
Consistent with
current individual
level estimate
There could be
SES confounding
at community level
Unclear
Paracetamol
(1st year)
1.28 (1.21,
1.36)
0.94 (0.69,
1.28)
The significantly
harmful effect
seen at the
individual level
doesn’t show at
the school-level
1.35 (1.26, 1.45)
(Beasley et al., 2008)
Consistent with
current individual
level estimate
Possible evidence
of reverse
causation
Unclear
Antibiotics
(1st year)
1.41 (1.34,
1.48)
1.35 (1.00,
1.82)
Consistent but
weaker
1.42 (1.33,1.51)
(Foliaki et al., 2009)
Consistent Confounding by
indication may
partly contribute to
the association.
Confounding by
indication may
contribute
Breastfed
ever
1.11 (1.05,
1.18)
1.06 (0.75,
1.48)
Consistent but
weaker
1.05 (0.97,1.12)
(Bjorksten et al., 2011)
Consistent No evidence of
reverse causation
bias
Weak association;
biological basis not
clear
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Cat (1st
year)
1.10 (1.03,
1.17)
1.15 (0.78,
1.71)
Consistent 1.09 (1.01,1.17)
(Brunekreef et al.,
2012a)
Consistent No evidence of
reverse causation
bias
-
Dog (1st
year)
1.05 (1.00,
1.11)
0.96 (0.69,
1.32)
Consistent Not available N/A No evidence of
effect
-
Farm
animals (1st
year)
1.16 (1.06,
1.27)
1.15 (0.62,
2.15)
Consistent 1.16 (1.07,1.27)
(Brunekreef et al.,
2012b)
Consistent No evidence of
reverse causation
bias
Proposed mechanism
related to endotoxin
exposure, although
unclear
2 or more
siblings
0.95 (0.90,
0.99)
1.11 (0.88,
1.40)
The estimates are
in opposing
directions but the
individual CI is
contained within
the school level
CI
dCategorical
No siblings 1.00 (ref)
One sibling 1.09 (1.03,
1.15)
2 siblings 1.01 (0.95,
1.08)
3+ siblings 1.04 (0.97,
1.12)
(Strachan et al., 2015)
Hard to compare
due to different
models
If there is an effect,
it appears small.
There is no dose
response
relationship (from
previous analysis)
-
Heavy truck
traffic
(current)
1.11 (1.06,
1.16)
0.81 (0.65,
1.02)
The estimates are
in opposing
directions with a
harmful effect at
the individual
level
dCategorical
Never 1.00 (ref)
Low 1.07 (0.99, 1.15)
Med 1.18 (1.09, 1.28)
Heavy 1.36 (1.23, 1.50)
(Brunekreef et al.,
2009)
Consistent with the
individual level
estimate
May relate to bias-
parents of children
with eczema may
move if they are
concerned about
traffic exposure
Unlikely causal
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Fast food
(current)
0.99 (0.94,
1.04)
0.96 (0.76,
1.22)
Consistent dCategorical
Never/Occasional 1.00
(ref)
1-2/wk 1.04 (0.99,
1.09)
3+/wk 1.04 (0.95, 1.14)
(Ellwood et al., 2013)
Consistent No evidence of
effect
-
Paternal
tobacco
(current)
1.04 (0.99,
1.10)
0.83 (0.61,
1.13)
The estimates are
in opposing
directions but the
confidence
intervals overlap
substantially
1.09 (1.04, 1.13)
(Mitchell et al., 2012)
Consistent with
individual level
effect
Very weak
association only
No dose response
relationship, unlikely
causal
Maternal
tobacco
(current)
1.06 (0.99,
1.13)
1.61 (1.14,
2.25)
The school level
harmful effect is
much greater
1.15 (1.09, 1.21)
(Mitchell et al., 2012)
Shows a stronger
effect than the
individual level in
the current analysis
No dose response
relationship, unlikely
causal
Paracetamol
(current)
1.45 (1.37,
1.54)
1.55 (1.10,
2.21)
Consistent dCategorical
Never/Low 1.00 (ref)
Med 1.18 (1.08,1.30)
High 1.87 (1.68,2.08)
(Beasley et al., 2008)
Consistent, the
high level is the
equivalent to a
positive response
in the current
analysis
No evidence of
reverse causation
bias
Depletion of
glutathione in antigen
presenting cells
resulting in a shift
from a Th1 to mainly
Th2 immune
response. (Beasley et
al., 2008, Peterson et
al., 1998)
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Open fire
cooking
(current)
1.12 (0.95,
1.32)
1.84 (0.98,
3.45)
Stronger harmful
effect seen at
school level
1.10 (0.91-1.33)
(Wong et al., 2013)
Consistent with
individual level
effect from current
analysis
Possible avoidance
bias as people with
children with AE
remove open fires,
masking the true
magnitude of effect
Persistent AE may be
associated with
impaired skin barrier
and more likely to
react to aeroallergens
and irritants
a - fully adjusted for sex, mothers’ education level and all other variables in the table
b - fully adjusted for sex, mothers’ education level and school level prevalence of all other variables in the table
c - could be adjusted for a variety of different variables
d - no direct comparison possible, so closest results are shown
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Table 4. Associations between eczema symptoms in the last 12 months and risk factors for 13-14 year old age group comparing results from different
analyses
Exposure
Current analysis Previous ISAAC analysis
Assessment of bias Biologicalplausibility of effectIndividual
levela
School levelb Comparison Individual levelc
Comparison with
current analysis
2 or more
siblings
1.08
(1.03,1.12)
1.26 (0.97,
1.65)
The school level
shows a stronger
harmful effect
although the CI
includes the full
individual level
dCategorical
No siblings 1.00 (ref)
One sibling 0.91 (0.85,
0.98)
2 siblings 0.96 (0.88,
1.03)
Consistent,
although not easy
to compare
May represent a
chance association.
No dose-response
relationship in
individual studies.
Heavy truck
traffic
(current)
1.31 (1.27,
1.36)
1.40 (1.07,
1.82)
Consistent dCategorical
Never 1.00 (ref)
Low 1.08 (0.97, 1.19)
Med 1.30 (1.17, 1.45)
Heavy 1.54 (1.37, 1.73)
(Brunekreef et al.,
2009)
Consistent No evidence of
reverse causation
bias
Previous studies
demonstrated dose-
response relationship
between levels of
exposure to traffic and
AE symptoms. No
clearly established
biological mechanism.
Inverse school-level
association found in
6-7-year-olds
contrasts with the
positive school-level
association shown
here for 13-14-year-
olds, suggesting
caution in drawing
firm conclusions
regarding causality.
37
Fast food
(current)
1.05 (1.02,
1.10)
2.11 (1.66,
2.70)
The school level
shows a stronger
harmful effect
dCategorical
Never/Occasional 1.00
(ref)
1-2/wk 1.04 (0.99,
1.10)
3+/wk 1.20 (1.11, 1.28)
(Ellwood et al., 2013)
Consistent with
individual level
effect in current
analysis
Possible avoidance
bias as people with
adolescents with AE
avoid fast food,
masking the true
magnitude of effect
Not fully understood;
theories around
ingested fatty acids
and inflammation.
Paternal
tobacco
(current)
1.15 (1.10,
1.19)
0.64 (0.44,
0.94)
The estimates
are in opposing
directions but
the confidence
intervals overlap
substantially;
school-level
estimates look
protective.
1.19 (1.14, 1.25)
(Mitchell et al., 2012)
Consistent with
individual level
effect in current
analysis
The finding might
support differential
reporting of tobacco
exposure in those
with current AE
symptoms or
ecologic bias at
school level
-
Maternal
tobacco
(current)
1.11 (1.06,
1.16)
0.79 (0.52,
1.19)
The estimates
are in opposing
directions but
the confidence
intervals overlap
substantially
1.22 (1.16, 1.28)
(Mitchell et al., 2012)
Stronger effect
than current
individual level
analysis
As for paternal
tobacco.
-
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Paracetamol
(current)
1.57 (1.51,
1.63)
2.57 (1.84,
3.59)
The school level
harmful effect is
much greater
dCategorical
Never/Low 1.00 (ref)
Med 1.31 (1.21, 1.42)
High 1.99 (1.82, 2.16)
(Beasley et al., 2011)
Consistent with
individual level
current analysis
(High is the same
as the positive
value in current
analysis)
Some evidence of
possible avoidance
bias masking the
true magnitude of
the harmful effect
Possible biological
mechanisms
underlying the
observed association
between paracetamol
use and AE may relate
to a depletion of
glutathione in antigen
presenting cells
resulting in a shift
from a Th1 to a
predominantly Th2
immune response
(Beasley et al., 2011,
Peterson et al., 1998).
Open fire
cooking
(current)
1.46 (1.33,
1.62)
2.38 (1.52,
3.73)
Stronger
harmful effect
seen at school
level.
1.37 (1.13-1.66)
(Wong et al., 2013)
Consistent with
individual level
effect in current
analysis
Possible avoidance
bias as people with
asthmatic children
remove open fires,
masking the true
magnitude of effect
Persistent AE may be
associated with
impaired skin barrier
and more likely to
react to aeroallergens
and irritants.
a - fully adjusted for sex, mothers’ education level and all other variables in the table
b - fully adjusted for sex, mothers’ education level and school level prevalence of all other variables in the table
c - could be adjusted for a variety of different variables
d - no direct comparison possible, so closest results are shown
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Figure legends
Fig. 1. Atopic eczema data flowchart, age 6-7 years
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Fig. 2. Atopic eczema data flowchart, age 13-14 years.
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Supplementary Material
Supplementary methods
Centre and school eligibility criteria
Only centres that met ISAAC methodology standards were included in the analysis. Excluded
centres were those with fewer than 1,000 participants or response rates below 60% for the 6-7
year-old age group or below 70% for the 13-14 year-olds. Centres were also excluded if they
did not return the Centre Report (Ellwood et al., 2005). Schools with fewer than 10
participants for a given age group were excluded from that analysis.
Environmental risk factors
Analyses in this paper included only the key environmental variables previously each singly
associated with AE in ISAAC at an individual-level. For the 6-7 year olds, risk factors were
paracetamol use in the first year of life and in the past 12 months (Beasley et al., 2008),
antibiotic use in the first year of life (Foliaki et al., 2009), breast feeding (Bjorksten et al.,
2011), cat and dog in the home in the first year of life (Brunekreef et al., 2012a), regular
contact with farm animals in the first year of life (Brunekreef et al., 2012b), regular maternal
contact with farm animals while pregnant (Brunekreef et al., 2012b), heavy truck traffic
(Brunekreef et al., 2009), fast food consumption (Ellwood et al., 2013), parental smoking
(Mitchell et al., 2012), cooking on an open fire (Wong et al., 2013), birthweight (Mitchell et
al., 2014) and number of siblings (Strachan et al., 2015). For the 13-14 year olds, risk factors
were heavy truck traffic (Brunekreef et al., 2009), fast food consumption (Ellwood et al.,
2013), parental smoking (Mitchell et al., 2012), paracetamol use in the past 12 months
(Beasley et al., 2011), open fire cooking (Wong et al., 2013), and number of siblings
(Strachan et al., 2015).
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Most of these items had simple “yes/no” answers. The exceptions have been dichotomised:
paracetamol use in the last 12 months (at least once per month vs. less than once per month),
heavy truck traffic (frequently or almost the whole day vs. seldom or never), fast food
consumption (once per week or more vs. less than once per week), low birthweight (less than
2.5 kg vs. at least 2.5 kg), and number of siblings (2 or more vs. 1 or fewer). Full definitions
of the environmental risk factors are in Table S2 of the Supplementary Material.
Derivation of affluence
Gross National Income (GNI) as of 2002 (obtained from the World Bank website (The World
Bank, 2016a) where available and filled in by the Central Intelligence Agency (CIA) World
Factbook (Central Intelligence Agency, 2002)) and a classification of affluent countries (GNI
over US$9,205) and non-affluent countries (GNI US$9,205 or lower) taken from the 2001
World Bank definition of high-income countries versus low- to middle-income countries
(The World Bank, 2016b).
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Table S1: Summary statistics in subjects with data for atopic eczema symptoms, sex, level of maternal education and the one exposure of interest
(the “maximum sample”).
Age group Variable Individual-level School-leveln Prevalence n Median prevalence Prevalence IQR
6-7 years
Atopic eczema in the last 12 months 204,771 0.074 2,851 0.067 (0.029, 0.116)
Farm animals (in utero) 181,600 0.100 2,630 0.078 (0.034, 0.156)
Low birthweight 169,993 0.085 2,549 0.063 (0.032, 0.106)
Paracetamol (1st year) 182,134 0.652 2,583 0.700 (0.563, 0.826)
Antibiotics (1st year) 180,799 0.540 2,663 0.559 (0.462, 0.646)
Breastfed ever 192,559 0.800 2,701 0.846 (0.736, 0.929)
Cat (1st year) 189,922 0.120 2,701 0.105 (0.048, 0.200)
Dog (1st year) 174,772 0.206 2,469 0.222 (0.123, 0.328)
Farm animals (1st year) 181,744 0.116 2,634 0.098 (0.046, 0.178)
2 or more siblings 203,603 0.381 2,851 0.375 (0.222, 0.544)
Heavy Truck traffic (current) 184,503 0.386 2,729 0.382 (0.278, 0.491)
Fast food (current) 181,864 0.411 2,798 0.333 (0.185, 0.511)
Paternal tobacco (current) 196,353 0.313 2,748 0.333 (0.193, 0.465)
Maternal tobacco (current) 199,522 0.141 2,781 0.140 (0.030, 0.301)
Paracetamol (current) 191,900 0.198 2,734 0.167 (0.079, 0.313)
Open fire cooking (current) 185,718 0.030 2,724 0.000 (0.000, 0.022)
13-14 years
Atopic eczema in the last 12 months 341,577 0.068 2,477 0.055 (0.027, 0.102)
2 or more siblings 334,708 0.552 2,402 0.621 (0.389, 0.810)
Heavy Truck traffic (current) 309,621 0.396 2,348 0.394 (0.303, 0.510)
Fast food (current) 313,066 0.552 2,388 0.552 (0.407, 0.695)
Paternal tobacco (current) 301,502 0.376 2,259 0.367 (0.239, 0.482)
Maternal tobacco (current) 329,659 0.181 2,433 0.183 (0.040, 0.333)
Paracetamol (current) 314,005 0.288 2,404 0.310 (0.195, 0.435)
Open fire cooking (current) 303,363 0.073 2,321 0.011 (0.000, 0.047)
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Table S2: Risk Factor definitions
Risk factors for ages 6-7 Question (asked to parent) Positive Response
Farm animals (in utero) Has the child’s mother had regular (at least once a week) contact with farm animals(e.g. cattle, pigs, goats, sheep or poultry) while being pregnant with this child? Yes
Low birthweight What was the weight of your child when he / she was born? Less than 2.5kg
Paracetamol (1st year) In the first 12 months of your child’s life, did you usually give paracetamol forfever? Yes
Antibiotics (1st year) In the first 12 months of your child’s life, did your child have any antibiotics? Yes
Breastfed ever Was your child breastfed? Yes
Cat (1st year) Did you have a cat in your home during the first year of your child’s life? Yes
Dog (1st year) Did you have a dog in your home during the first year of your child’s life? Yes
Farm animals (1st year) In your child’s first year of life, did he / she have regular (at least once a week)contact with farm animals (e.g. cattle, pigs, goats, sheep or poultry)? Yes
2 or more siblings How many older and younger brothers and sisters does your child have? Total of 2 or more
Heavy truck traffic (current) How often do trucks pass through the street where you live, on weekdays? Frequently or almost the whole day
Fast food (current) In the past 12 months, how often, on average did your child eat fast food / burgers? At least once a week
Paternal tobacco (current) Does your child’s father (or male guardian) smoke cigarettes? Yes
Maternal tobacco (current) Does your child’s mother (or female guardian) smoke cigarettes? Yes
Paracetamol (current) In the past 12 months, how often, on average, have you given your childparacetamol? At least once a month
Open fire cooking (current) In your house, what fuels are usually used for cooking? Electricity, Gas, Open fires,Other Any that include open fires
Risk factors for ages 13-14 Question (asked to child) Positive Response
2 or more siblings How many older and younger brothers and sisters do you have? Total of 2 or more
Heavy truck traffic (current) How often do trucks pass through the street where you live, on weekdays? Frequently or almost the whole day
Fast food (current) In the past 12 months, how often, on average did you eat fast food / burgers? At least once a week
Paternal tobacco (current) Does your father (or male guardian) smoke cigarettes? Yes
Maternal tobacco (current) Does your mother (or female guardian) smoke cigarettes? Yes
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Paracetamol (current) In the past 12 months, how often, on average, have you taken paracetamol? At least once a month
Open fire cooking (current) In your house, what fuels are usually used for cooking? Electricity, Gas, Open fires,Other Any that include open fires
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Table S3. Minimally adjustedA effects of individual- and school-level exposures on atopic eczema symptoms in the last 12 months in subjects
with data for atopic eczema symptoms, sex, level of maternal education and the one exposure of interest (the “maximum sample”). Mixed
logistic regression models with random intercepts at the school, centre and country levels.
Age group Exposure Individual-level exposure School-level exposuren OR (95% CI) n OR (95% CI)
6-7 years
Farm animals (in utero) 181,600 1.37 (1.29, 1.45) 181,600 1.85 (1.39, 2.45)
Low birthweight 169,993 0.93 (0.86, 1.00) 169,993 1.65 (1.07, 2.55)
Paracetamol (1st year) 182,134 1.55 (1.48, 1.62) 182,134 1.12 (0.87, 1.44)
Antibiotics (1st year) 180,799 1.60 (1.53, 1.66) 180,799 1.29 (1.00, 1.66)
Breastfed ever 192,559 1.09 (1.04, 1.14) 192,559 0.94 (0.69, 1.26)
Cat (1st year) 189,922 1.27 (1.21, 1.34) 189,922 1.79 (1.33, 2.41)
Dog (1st year) 174,772 1.16 (1.11, 1.21) 174,772 1.48 (1.14, 1.92)
Farm animals (1st year) 181,744 1.41 (1.34, 1.49) 181,744 2.06 (1.56, 2.72)
2 or more siblings 203,603 0.98 (0.94, 1.01) 203,603 1.44 (1.20, 1.73)
Heavy Truck traffic (current) 184,503 1.19 (1.14, 1.23) 184,503 1.15 (0.94, 1.39)
Fast food (current) 181,864 1.03 (0.99, 1.07) 181,864 0.84 (0.69, 1.02)
Paternal tobacco (current) 196,353 1.11 (1.07, 1.16) 196,353 1.27 (1.01, 1.60)
Maternal tobacco (current) 199,522 1.17 (1.11, 1.22) 199,522 1.61 (1.24, 2.09)
Paracetamol (current) 191,900 1.60 (1.53, 1.67) 191,900 1.69 (1.28, 2.23)
Open fire cooking (current) 185,718 1.14 (1.02, 1.29) 185,718 2.98 (1.83, 4.85)
Age group Exposure Individual-level exposure School-level exposuren OR (95% CI) n OR (95% CI)
13-14 years
2 or more siblings 334,708 1.06 (1.03, 1.10) 334,708 1.25 (0.99, 1.57)
Heavy Truck traffic (current) 309,621 1.31 (1.27, 1.35) 309,621 1.53 (1.20, 1.96)
Fast food (current) 313,066 1.09 (1.06, 1.13) 313,066 1.85 (1.48, 2.32)
Paternal tobacco (current) 301,502 1.22 (1.18, 1.26) 301,502 0.72 (0.54, 0.96)
Maternal tobacco (current) 329,659 1.23 (1.19, 1.28) 329,659 0.91 (0.66, 1.24)
Paracetamol (current) 314,005 1.57 (1.52, 1.62) 314,005 2.14 (1.59, 2.88)
Open fire cooking (current) 303,363 1.43 (1.34, 1.53) 303,363 1.50 (1.09, 2.06)
AAdjusted for sex and mothers level of education.
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Table S4. Fully adjustedA effects of individual-level exposures on atopic eczema symptoms in the last 12 months in subjects with data for atopic
eczema symptoms, sex, maternal education and all exposures of interest (the “common sample”), stratified by country-level affluence. Mixed
logistic regression models with random intercepts at the school, centre and country levels.
Age
group Exposure
Affluent Countries
(n = 43,374)
Non-Affluent countries
(n = 77,425)
Effect
modification
p-valueNumber exposed (%) OR (95% CI) Number exposed (%) OR (95% CI)
6-7 years
Farm animals (in utero) 2,970 (6.8) 1.00 (0.84, 1.20) 6,365 (8.2) 1.19 (1.06, 1.35) <0.001
Low birthweight 2,508 (5.8) 0.92 (0.80, 1.06) 6,763 (8.7) 0.85 (0.76, 0.96) 0.51
Paracetamol (1st year) 27,222 (62.8) 1.29 (1.17, 1.41) 52,751 (68.1) 1.30 (1.21, 1.40) 0.93
Antibiotics (1st year) 22,736 (52.4) 1.44 (1.34, 1.55) 44,504 (57.5) 1.37 (1.28, 1.47) 0.33
Breastfed ever 29,658 (68.4) 1.16 (1.07, 1.25) 67,532 (87.2) 1.05 (0.97, 1.15) 0.11
Cat (1st year) 6,717 (15.5) 1.01 (0.92, 1.10) 6,508 (8.4) 1.21 (1.09, 1.33) <0.001
Dog (1st year) 8,102 (18.7) 0.98 (0.90, 1.06) 15,790 (20.4) 1.09 (1.02, 1.17) <0.001
Farm animals (1st year) 3,688 (8.5) 0.96 (0.81, 1.13) 7,662 (9.9) 1.29 (1.15, 1.44) <0.001
2 or more siblings 12,887 (29.7) 0.95 (0.89, 1.03) 29,066 (37.5) 0.93 (0.87, 1.00) 0.95
Heavy Truck traffic 14,353 (33.1) 1.07 (1.00, 1.15) 31,515 (40.7) 1.14 (1.07, 1.21) 0.14
Fast food (current) 13,496 (31.1) 1.05 (0.97, 1.13) 34,343 (44.4) 0.96 (0.89, 1.02) 0.10
Paternal tobacco (current) 16,991 (39.2) 1.05 (0.98, 1.14) 21,468 (27.7) 1.04 (0.97, 1.11) 0.40
Maternal tobacco 12,058 (27.8) 1.00 (0.92, 1.08) 7,620 (9.8) 1.15 (1.05, 1.26) 0.008
Paracetamol (current) 5,011 (11.6) 1.64 (1.49, 1.79) 16,724 (21.6) 1.35 (1.25, 1.45) 0.003
Open fire cooking 255 (0.6) 1.09 (0.73, 1.63) 2,000 (2.6) 1.10 (0.92, 1.33) 0.60
Age
group Exposure
Affluent Countries
(n=48,626)
Non-Affluent Countries
(n=184,533)
Effect
modification
p-valueNumber exposed (%) OR (95% CI) Number exposed (%) OR (95% CI)
13-14
years
2 or more siblings 18,086 (37.2) 1.06 (0.97, 1.16) 108,122 (58.6) 1.08 (1.03, 1.13) 0.51
Heavy Truck traffic 17,725 (36.5) 1.32 (1.21, 1.44) 74,568 (40.4) 1.31 (1.26, 1.37) 0.81
Fast food (current) 24,780 (51.0) 1.06 (0.97, 1.15) 100,139 (54.3) 1.06 (1.01, 1.10) 0.79
Paternal tobacco (current) 19,486 (40.1) 1.05 (0.96, 1.14) 70,043 (38.0) 1.17 (1.12, 1.23) 0.01
Maternal tobacco 14,713 (30.3) 1.09 (0.99, 1.20) 27,899 (15.1) 1.12 (1.06, 1.18) 0.31
Paracetamol (current) 13,211 (27.2) 1.75 (1.60, 1.92) 49,682 (26.9) 1.53 (1.47, 1.60) 0.007
Open fire cooking 513 (1.1) 1.55 (1.10, 2.18) 11,565 (6.3) 1.44 (1.30, 1.60) 0.73
AAdjusted for sex, mother's level of education and all other variables in the table.
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Table S5: Fully adjustedA effects of school-level exposures on prevalence on atopic eczema symptoms in the last 12 month in subjects with data
for atopic eczema symptoms, sex, maternal education and all exposures of interest (the “common sample”), stratified by country-level affluence.
Mixed logistic regression models with random intercepts at the school, centre and country levels.
Age group Exposure
Affluent countries
(n = 43,374)
Non-affluent countries
(n = 77,425)
Effect
modification
p-valueMedian prevalence OR (95% CI) Median prevalence OR (95% CI)
6-7 years
Farm animals (in utero) 0.06 1.51 (0.56, 4.03) 0.07 0.77 (0.30, 1.97) 0.13
Low birthweight 0.05 1.16 (0.49, 2.73) 0.06 1.87 (0.94, 3.70) 0.19
Paracetamol (1st year) 0.76 1.29 (0.82, 2.05) 0.68 0.88 (0.58, 1.34) 0.28
Antibiotics (1st year) 0.57 1.39 (0.91, 2.12) 0.58 1.23 (0.79, 1.90) 0.41
Breastfed ever 0.74 1.15 (0.77, 1.71) 0.89 0.83 (0.45, 1.54) 0.35
Cat (1st year) 0.10 1.02 (0.64, 1.64) 0.08 1.45 (0.68, 3.09) 0.03
Dog (1st year) 0.19 0.79 (0.51, 1.24) 0.21 1.18 (0.72, 1.92) 0.03
Farm animals (1st year) 0.08 0.57 (0.22, 1.47) 0.09 1.86 (0.81, 4.31) 0.02
2 or more siblings 0.28 1.01 (0.72, 1.40) 0.36 1.08 (0.77, 1.51) 0.44
Heavy Truck traffic (current) 0.33 0.83 (0.60, 1.14) 0.40 0.83 (0.60, 1.16) 0.77
Fast food (current) 0.27 0.79 (0.54, 1.17) 0.36 1.11 (0.81, 1.52) 0.34
Paternal tobacco (current) 0.42 1.02 (0.67, 1.55) 0.29 0.61 (0.38, 0.99) 0.57
Maternal tobacco (current) 0.30 1.43 (0.96, 2.14) 0.08 1.88 (1.01, 3.51) 0.54
Paracetamol (current) 0.12 2.05 (1.23, 3.42) 0.17 1.35 (0.83, 2.22) 0.38
Open fire cooking (current) 0.00 2.75 (0.40, 18.79) 0.00 1.62 (0.80, 3.27) 0.97
Age group Exposure
Affluent countries
(n = 48,626)
Non-affluent countries
(n = 184,533)
Effect
modification
p-valueMedian prevalence OR (95% CI) Median prevalence OR (95% CI)
13-14 years
2 or more siblings 0.35 1.26 (0.76, 2.10) 0.68 1.33 (0.97, 1.82) 0.16
Heavy Truck traffic (current) 0.37 0.99 (0.53, 1.84) 0.40 1.47 (1.10, 1.97) 0.12
Fast food (current) 0.50 1.40 (0.80, 2.43) 0.55 2.42 (1.84, 3.20) 0.03
Paternal tobacco (current) 0.43 0.45 (0.21, 0.95) 0.34 0.73 (0.47, 1.12) 0.16
Maternal tobacco (current) 0.35 1.46 (0.68, 3.12) 0.13 0.64 (0.39, 1.04) 0.48
Paracetamol (current) 0.30 2.38 (1.26, 4.51) 0.29 2.62 (1.79, 3.85) 0.58
Open fire cooking (current) 0.00 1.08 (0.04, 26.81) 0.01 2.26 (1.40, 3.66) 0.45
AAdjusted for sex, mother's level of education and all other variables in the table.
